ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Based on the sub-clone concept of stem cell evolution in CML [31, 32] the clinical effect is best explained by TKI-induced eradication of stem cell-derived sub-clones [33] which was confirmed by demonstrating the complete disappearance of BCR-ABL1-bearing cells in our patient.